Thymosin Beta 4 (TB500) 5mg

Thymosin Beta 4 (TB500) 5mg

$31.98 $79.95Save 60%
Quality Icon
  • Free Priority Shipping
  • Orders over $75
  • Quality Icon
  • Rewards Icon
  • 3rd Party Tested

Buy Thymosin Beta 4 (TB500) 5MG :

Unit Size 5 mg/vial
Unit Quantity 1 vial
Purity (Mass Spectrometry and UV) 99.92%
Sequence Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-
Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-
Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH
Molecular Formula C212H350N56O78S
Appearance Lyophilized White Powder
Source Chemical Synthesis
Storage Lyophilized TB500 is stable at room
temperature for 90 days; however, it is best stored
in a freezer at -20°C for any extended
period of time.
Terms The products we offer are intended for laboratory
research use only. Please familiarize yourself with
our terms of service prior to ordering.
COA Verification Verify this COA on MZ Biolabs →

Thymosin Beta 4 (TB500) 5mg

All content and product information provided on this website are for informational and educational research purposes only. This product is not intended for human consumption, diagnostic use, or therapeutic use.
View Research Overview & References

Thymosin Beta 4 is a 43-amino-acid protein and the most abundant member of the beta-thymosin family of low molecular weight acidic peptides, found in nearly all cell types.

It functions as the principal G-actin sequestering peptide in the cytoplasm, forming a 1:1 complex with actin monomers that inhibits their polymerization into filaments.1

Living-Cell Actin Regulation Findings

In vitro research microinjecting synthetic Thymosin Beta 4 into cultured epithelial cells and fibroblasts found a dose-dependent depolymerization of actin filaments and diminished stress fibers, confirming the peptide's actin-sequestering activity within an intact cellular environment rather than in isolated protein solution alone.2

Vial Sizing for Larger-Scale Experimental Designs

A 5 mg vial provides a larger total peptide mass per container than smaller unit sizes, making it a practical choice for laboratories running serial comparisons or multiple parallel in vitro assays that require a larger total quantity of starting material.

Researchers running higher-throughput experimental designs often select larger unit sizes specifically to avoid needing multiple separate production batches within a single study.

Structural Basis of Actin Sequestration

Thymosin Beta 4's function as an actin monomer buffer is linked to its low isoelectric point and high proportion of acidic residues, properties thought to mediate electrostatic contact with the actin monomer surface.

Researchers comparing beta-thymosin family members for use in cytoskeletal assay systems have pointed to this acidic charge profile as a structural feature distinguishing beta-thymosins from other actin-binding proteins that regulate filament assembly through different mechanisms.

Analytical Identity Confirmation for Larger Peptide Batches

Because Thymosin Beta 4 is a comparatively large, 43-residue peptide, analytical confirmation of identity across an entire production batch is a more involved process than for shorter research peptides.

Laboratories typically rely on mass spectrometry to confirm the intact peptide mass and HPLC to assess chromatographic purity, with particular attention paid to detecting partial-length synthesis products that can co-elute closely with the full-length peptide.

TB500 in the Context of Cytoskeletal Dynamics Research

Thymosin Beta 4 was first isolated from thymic tissue in the 1960s and has since become one of the most extensively studied members of the beta-thymosin family, which also includes thymosin beta-10 and thymosin beta-15.

Laboratory research comparing these isoforms has focused on differences in tissue expression patterns and relative actin-binding affinity, using Thymosin Beta 4 as the reference compound given the depth of existing structural and functional data.

A Native Sequence Rather Than an Engineered Analog

Most synthetic research peptides are modified versions of a natural sequence, carrying D-amino acids, non-standard residues, or deliberate substitutions intended to resist enzymatic breakdown. This one is not.

The forty-three residues shown in the specification table reproduce the native Thymosin Beta 4 sequence exactly, and even the N-terminal acetyl group is present in the natural protein rather than added for stability. Every residue is a standard L-amino acid.

That makes this peptide useful as a reference material in cytoskeletal work, since results obtained with it are not complicated by the question of whether an engineered modification altered the behavior being measured.

A Peptide Without a Fixed Shape

Thymosin Beta 4 belongs to the class of intrinsically disordered peptides. On its own it does not fold into a single stable three-dimensional structure the way a globular protein does, instead sampling a range of extended conformations.

Structure appears when it binds its partner: contact with an actin monomer organizes parts of the chain into defined elements that are not present beforehand. This coupling of folding to binding is why structural studies of this peptide are usually carried out on the complex rather than on the peptide in isolation.

The high proportion of charged residues described above is characteristic of disordered peptides generally, since charge repulsion along the chain discourages it from collapsing into a compact fold.

Nine Lysines and What That Means for Peptide Mapping

The sequence carries nine lysine residues and no arginine. Trypsin, the enzyme most often used for peptide mapping, cleaves after both, so this peptide presents nine cleavage sites across forty-three residues.

A tryptic digest therefore produces a relatively large number of short fragments rather than a handful of long ones. That yields a detailed map useful for confirming the full sequence, though the short fragments require a method capable of resolving closely spaced low-mass species.

Alternate Names in the Literature

This peptide appears in published work and supplier catalogs as Thymosin Beta 4, Thymosin β4, Tβ4, TB-500, TB500, and in older literature as Fx peptide. Each refers to the same forty-three-residue sequence shown in the specification table above.

Important Notice

TB500 is intended exclusively for in vitro laboratory research use only. It is not approved for human use, diagnostic use, or therapeutic use, and has not been evaluated for safety or efficacy in humans.

Product Information

TB500 is available as a white lyophilized powder at 5 mg per vial, strictly for in vitro laboratory use.

References

1. Huff T, Müller CS, Otto AM, Netzker R, Hannappel E. Beta-Thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol. 2001 Mar;33(3):205-20.
2. Sanders MC, Goldstein AL, Wang YL. Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4678-4682.

Related Research products
  1. BPC 157 5mg
    BPC 157 5mg
    $31.18
  2. KPV 5mg
    KPV 5mg
    $19.98
  3. Blue Sky Storage Box (10)
    Blue Sky Storage Box (10)
    $14.99
  4. Storage Case (10)
    Storage Case (10)
    $9.99